Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03660861
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CFX | CEFOXITIN | A,B | 1YMX | 0.71 |  |
| CFX | CEFOXITIN | A,B | 1I2W | 0.71 | |
CTB | N-2-THIOPHEN-2-YL-ACETAMIDE BORONIC ACID | A,B | 1FSW | 0.73 | |
THN | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYLENE-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 1 | |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.72 | |
3SP | N-(CARBOXYMETHYL)-3-CYCLOHEXYL- D-ALANYL-N-({5-[(E)-AMINO(IMINO)METHYL]THIEN- 2-YL}METHYL)-L-PROLINAMIDE | D,H | 2FES | 0.73 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.75 | |
CS3 | S-[3-OXO-3-(2-THIENYL)PROPYL]-L- CYSTEINE | A | 2OQW | 0.7 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.71 | |
PNN | PENICILLIN G | A,B | 1GM7 | 0.7 | |
| PNN | PENICILLIN G | B | 1FXV | 0.7 | |
| PNN | PENICILLIN G | A | 1UOF | 0.7 | |
| PNN | PENICILLIN G | A | 1UOB | 0.7 | |
CED | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A | 1GHM | 0.81 | |
CEO | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVM | 0.88 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1JK3 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1MMB | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 2RJQ | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1RM8 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 2J83 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 1DTH | 0.71 | |
ZED | L-PROLINE, 1-[(2S)-3-MERCAPTO-2- METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)- , 4S | A | 2EWB | 0.72 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1PI4 | 0.73 | |
| SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 2FFY | 0.73 | |
| SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1MY8 | 0.73 | |
SM4 | (1R)-1-(2-THIOPHEN-2-YL-ACETYLAMINO)- 1-(3-(2-CARBOXYVINYL)-PHENYL) METHYLBORONIC ACID | A,B | 2RCX | 0.72 | |
NCF | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}- 5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | A,B,C,D | 1W8Y | 0.87 | |
CEP | CEPHALOTHIN GROUP | A | 1CEG | 0.81 | |
| CEP | CEPHALOTHIN GROUP | A | 1IYP | 0.81 | |
TIH | BETA(2-THIENYL)ALANINE | A | 1MMK | 0.73 | |
| TIH | BETA(2-THIENYL)ALANINE | B | 1EOJ | 0.73 | |
| TIH | BETA(2-THIENYL)ALANINE | A | 1KW0 | 0.73 | |
| TIH | BETA(2-THIENYL)ALANINE | A | 1BDK | 0.73 | |
KCP | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYL-3,6-DIHYDRO-2H- [1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.83 | |